Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Herantis Pharma Oyj
OYJ
Active
Y-tunnus 2198665-7
Bertel Jungin Aukio 1, 02600
Espoo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2008 · 18 years old
— employees
www.herantis.com
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Herantis Pharma Oyj
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AT
Antti Tapani Vuolanto
Chief Executive Officer
Chief Executive Officer
2022
Former (4)
CR
Craig Richard Cook
Chief Executive Officer
Chief Executive Officer
2020 – 2022
PI
Pekka Ilmari Simula
Chief Executive Officer
Chief Executive Officer
2014 – 2020
MA
Martin Andreas Grandell
Audit
Audit
2008 – 2021
PV
Panu Veijo Ilmari Vänskä
Audit
Audit
2021 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
TI
Timo Ilari Veromaa
Chairperson
Chairperson
2020
FG
Frans Gustaf Wuite
Board of Directors
Board of Directors
2015
AP
Aki Pellervo Prihti
Board of Directors
Board of Directors
2015
HF
Hilde Furberg
Board of Directors
Board of Directors
2021
MJ
Mats Johan Peter Thorén
Board of Directors
Board of Directors
2020
Former (3)
IA
Ingrid Atteryd Heiman
Board of Directors
Board of Directors
2019 – 2020
JN
James Neil Phillips
Board of Directors
Board of Directors
2015 – 2023
PA
Pekka Allan Antero Mattila
Chairperson
Chairperson
2015 – 2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Herantis Pharma Oyj
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network